JACOBS LEVY EQUITY MANAGEMENT, INC

Position in LNTH — Lantheus Holdings, Inc.

CIK 884414 FLORHAM PARK, NJ

Back to LNTH Full portfolio

Position in LNTH

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$43,814,373

+$31,681,976 QoQ

Shares Held

577,645

+216.9% QoQ

Ownership

0.887%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

8 quarters on record

Voting authority Sole 79.0980619584693.ToString("F0")% Shared 0.ToString("F0")% None 20.9019380415307.ToString("F0")%

Common Shares in LNTH Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $198,176,624 across 13 Drug Manufacturers - Specialty & Generic names. LNTH ranks #2 (22.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	520,269	$68,540,238
2	LNTH	Lantheus Holdings, Inc. This page	577,645	$43,814,373
3	ZTS	Zoetis Inc.	304,877	$36,039,510
4	IRWD	Ironwood Pharmaceuticals Inc	3,632,477	$12,749,994
5	BCRX	Biocryst Pharmaceuticals Inc	1,004,373	$9,561,630
6	BIOA	BioAge Labs, Inc.	420,123	$7,347,951
7	PAHC	Phibro Animal Health Corp	114,018	$6,306,335
8	PCRX	Pacira BioSciences, Inc.	188,186	$4,253,003

All Filings in LNTH

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$43,814,373	577,645	+216.9%	Shares	Sole	2026-05-15
2025-12-31	$12,132,397	182,305	+33.1%	Shares	Sole	2026-02-13
2025-09-30	$7,022,831	136,924	+409.0%	Shares	Sole	2025-11-17
2024-12-31	$2,406,474	26,900	-25.4%	Shares	Sole	2025-02-14
2020-12-31	$486,624	36,073	-40.0%	Shares	Sole	2021-02-16
2020-09-30	$761,682	60,117	-40.1%	Shares	Sole	2020-11-16
2020-06-30	$1,434,862	100,340	+314.7%	Shares	Sole	2020-08-17
2020-03-31	$308,702	24,193	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.